These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15642175)

  • 1. p21-activated kinase signaling in breast cancer.
    Gururaj AE; Rayala SK; Kumar R
    Breast Cancer Res; 2005; 7(1):5-12. PubMed ID: 15642175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectors for the Rho GTPases.
    Aspenström P
    Curr Opin Cell Biol; 1999 Feb; 11(1):95-102. PubMed ID: 10047515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p21-activated kinases in cancer.
    Kumar R; Gururaj AE; Barnes CJ
    Nat Rev Cancer; 2006 Jun; 6(6):459-71. PubMed ID: 16723992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p21-Activated kinase 5: a pleiotropic kinase.
    Wen YY; Wang XX; Pei DS; Zheng JN
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6636-9. PubMed ID: 24215894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signaling intricacies take center stage in cancer cells.
    Kumar R; Hung MC
    Cancer Res; 2005 Apr; 65(7):2511-5. PubMed ID: 15805240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sliding p21-activated kinase 1 to nucleus impacts tamoxifen sensitivity.
    Rayala SK; Kumar R
    Biomed Pharmacother; 2007 Aug; 61(7):408-11. PubMed ID: 17604944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A brain serine/threonine protein kinase activated by Cdc42 and Rac1.
    Manser E; Leung T; Salihuddin H; Zhao ZS; Lim L
    Nature; 1994 Jan; 367(6458):40-6. PubMed ID: 8107774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear p21-activated kinase 1 in breast cancer packs off tamoxifen sensitivity.
    Rayala SK; Molli PR; Kumar R
    Cancer Res; 2006 Jun; 66(12):5985-8. PubMed ID: 16778166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rac1 and RhoG promote cell survival by the activation of PI3K and Akt, independently of their ability to stimulate JNK and NF-kappaB.
    Murga C; Zohar M; Teramoto H; Gutkind JS
    Oncogene; 2002 Jan; 21(2):207-16. PubMed ID: 11803464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biology of the p21-activated kinases.
    Bokoch GM
    Annu Rev Biochem; 2003; 72():743-81. PubMed ID: 12676796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
    Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of the multifunctional Trio protein in the control of the Rac1 and RhoA gtpase signaling pathways].
    Bellanger JM; Zugasti O; Lazaro JB; Diriong S; Lamb N; Sardet C; Debant A
    C R Seances Soc Biol Fil; 1998; 192(2):367-74. PubMed ID: 9759378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. alphaPIX nucleotide exchange factor is activated by interaction with phosphatidylinositol 3-kinase.
    Yoshii S; Tanaka M; Otsuki Y; Wang DY; Guo RJ; Zhu Y; Takeda R; Hanai H; Kaneko E; Sugimura H
    Oncogene; 1999 Oct; 18(41):5680-90. PubMed ID: 10523848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of Ras activation in human breast cancer cell signaling, invasion, and anoikis.
    Eckert LB; Repasky GA; Ulkü AS; McFall A; Zhou H; Sartor CI; Der CJ
    Cancer Res; 2004 Jul; 64(13):4585-92. PubMed ID: 15231670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new rac target POSH is an SH3-containing scaffold protein involved in the JNK and NF-kappaB signalling pathways.
    Tapon N; Nagata K; Lamarche N; Hall A
    EMBO J; 1998 Mar; 17(5):1395-404. PubMed ID: 9482736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rho-kinase (ROK) promotes CD44v(3,8-10)-ankyrin interaction and tumor cell migration in metastatic breast cancer cells.
    Bourguignon LY; Zhu H; Shao L; Zhu D; Chen YW
    Cell Motil Cytoskeleton; 1999; 43(4):269-87. PubMed ID: 10423269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signaling pathways in phagocytosis.
    Kwiatkowska K; Sobota A
    Bioessays; 1999 May; 21(5):422-31. PubMed ID: 10376013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynein light chain 1, a p21-activated kinase 1-interacting substrate, promotes cancerous phenotypes.
    Vadlamudi RK; Bagheri-Yarmand R; Yang Z; Balasenthil S; Nguyen D; Sahin AA; den Hollander P; Kumar R
    Cancer Cell; 2004 Jun; 5(6):575-85. PubMed ID: 15193260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caspase-mediated activation of PAK2 during apoptosis: proteolytic kinase activation as a general mechanism of apoptotic signal transduction?
    Bokoch GM
    Cell Death Differ; 1998 Aug; 5(8):637-45. PubMed ID: 10200518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p21ras initiates Rac-1 but not phosphatidyl inositol 3 kinase/PKB, mediated signaling pathways in T lymphocytes.
    Genot E; Reif K; Beach S; Kramer I; Cantrell D
    Oncogene; 1998 Oct; 17(13):1731-8. PubMed ID: 9796702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.